Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousRemission InductionAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaCyclophosphamideTransplantation ChimeraBone Marrow PurgingCombined Modality TherapyLiver TransplantationBone Marrow DiseasesHematopoietic Stem CellsGraft SurvivalBusulfanTissue DonorsTreatment OutcomeHistocompatibility TestingRecurrenceHistocompatibilityBone Marrow ExaminationLeukemia, Myeloid, AcuteHematopoiesisTransplantation, IsogeneicBone Marrow NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsMice, Inbred C57BLKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraSurvival AnalysisLeukemia, MyeloidImmunosuppressive AgentsLymphoma, Non-HodgkinRemission, SpontaneousHematologic NeoplasmsAcute DiseaseDisease-Free SurvivalGraft RejectionCytarabineHepatic Veno-Occlusive DiseaseColony-Forming Units AssayStem Cell TransplantationChemotherapy, AdjuvantSurvival RateEtoposideBone RemodelingGraft vs Host ReactionLymphocyte DepletionImmunosuppressionTransplantation ImmunologyMyelodysplastic SyndromesFollow-Up StudiesLeukocyte TransfusionPrognosisT-LymphocytesActuarial AnalysisHematologic DiseasesRetrospective StudiesHeart TransplantationChimeraCarmustineAntineoplastic AgentsSevere Combined ImmunodeficiencyGranulocyte Colony-Stimulating FactorMethotrexateHLA AntigensCyclosporineMelphalanCell DifferentiationLeukocyte CountLymphocyte TransfusionPancytopeniaHodgkin DiseaseMultiple MyelomaLymphomaLung TransplantationBone DensityFlow CytometrySpleenDoxorubicinNuclear FamilyGraft vs Tumor EffectMice, Inbred BALB CGraft vs Leukemia EffectCells, CulturedAntigens, CD34Antibodies, MonoclonalOrgan TransplantationFatal OutcomeSalvage Therapy